About paclitaxel -300 mg
Discover spectacular results with Paclitaxel - 300 mg injection, formulated to USP/BP standards and engineered for excellence in cancer chemotherapy. This rare, ravishing drug is offered at competitive pricing during our exclusive clearance event. Each polished, single-use glass vial delivers 300 mg/50 mL (6 mg/mL) of paclitaxel in a clear, colorless to pale yellow ready-to-use solution, designed for intravenous infusion. Ideal for treating ovarian, breast, non-small cell lung cancers, and Kaposi's sarcoma. Sterile, pyrogen-free, and meets cytostatic handling standards. Secure yours now-stock is limited!
Competitive Edge for Oncological Chemotherapy
Paclitaxel - 300 mg offers a robust competitive advantage with its potent cytostatic action and precise formulation. Designed for intravenous use, it satisfies high standards of sterility and effectiveness. Suitable for hospitals, oncology centers, and specialized clinics requiring ready-to-use solutions with no reconstitution. Its versatility targets multiple cancer types, making it indispensable in advanced therapeutic protocols.
FOB Port, Samples, and Swift Global Delivery
With strong market value and stock ready for dispatch, Paclitaxel - 300 mg ships efficiently from designated FOB ports. We offer a flexible sample policy to ensure quality assurance prior to bulk orders. Expect timely freight and delivery times, minimizing wait and maximizing operational readiness for distributors, exporters, and medical facilities worldwide.
FAQ's of paclitaxel -300 mg:
Q: How should Paclitaxel - 300 mg injection be administered?
A: Paclitaxel - 300 mg injection should be administered via intravenous infusion under the supervision of qualified healthcare professionals in medical facilities.
Q: What precautions are necessary when handling this product?
A: As a cytotoxic agent, handle Paclitaxel using appropriate PPE and treat it as hazardous to minimize occupational exposure risks.
Q: Where is this injection best suited for use?
A: This drug is best suited for oncology centers, specialized hospitals, and pharmacies equipped for intravenous chemotherapy administration.
Q: What cancers can Paclitaxel - 300 mg help treat?
A: It is indicated for ovarian cancer, breast cancer, non-small cell lung cancer, and Kaposi's sarcoma.
Q: Is reconstitution required before administration?
A: No reconstitution is necessary; Paclitaxel - 300 mg comes ready-to-use, streamlining preparation and administration processes.